Posted by AGORACOM-JC
at 9:00 PM on Sunday, October 25th, 2020
SPONSOR: FansUnite Entertainment Inc (FANS:CSE) The global online gambling market could potentially hit $1 TRILLION by the end of this decade. FansUnite is well positioned to capitalize on this trend. The company has a full suite of B2B and B2C services and has facilitated over $350M in bets from its 300,000 registered users. Learn More.
The rise of Esports amid an entertainment shift
A seismic shift has been taking place in the world of entertainment with live streaming disturbing the sector as we know it
The popularity of live streaming is increasing globally, changing the face of communication, sports and business
Cinema may be in a death spiral, and home-working is now socially acceptable
Meanwhile, Esports and gaming are bucking this new trend with their rising popularity in 2020, in a movement that’s set to continue.
A seismic shift has been taking place in the world of entertainment with live streaming disturbing the sector as we know it. The popularity of live streaming is increasing globally, changing the face of communication, sports and business. Cinema may be in a death spiral, and home-working is now socially acceptable. Meanwhile, Esports and gaming are bucking this new trend with their rising popularity in 2020, in a movement that’s set to continue.
Within the gaming space new companies are making waves, while established companies are enjoying a bull run on valuations. This is driving investment into the sector and witnessing a monumental cash injection from several angles.
Esports brings the competitive nature of traditional sports to the video game arena. Boosted and made possible by live streaming. Entire brands are being constructed around various aspects of the gaming industry, with variety coming in a spectrum of ingenious ideas; from focus-boosting chewing gum to designer gaming chairs, patented hoodies, and an assortment of must-have peripherals and fashion accessories.
Celebrities, from A-List to Z, are onboard, and many youngsters are finding fame and fortune within the sector. While it’s highly focussed on the youth of today, older sports fans and ex-competitors are finding themselves involved in helping train, encourage and simply enjoy the spectating experience. Charitable events are becoming commonplace, to both benefit from and boost awareness of the sector and its growing sea of brands. Meanwhile, money-spinning events are making gamers and their backers filthy rich. Esports: Three Billion Players by 2023 – Image taken from Newzoo website
As the Covid-19 pandemic wreaks havoc on the world, increasing the divide between winners and losers, the entertainment industry echoes this sentiment. Many companies involved in gaming are thriving this year. It’s not just the video game manufacturers. There’s a glut of new angles to making money from the sector, such as gambling on Esporting events. From Esports to gaming accessories, media giants to funds, our in-depth report covers the basics and much more.
Will innovation reign supreme or is there plenty of room for everyone? This remains a relatively new space for investment, and the colossal sums of money to be made are increasingly tempting.
Posted by AGORACOM-JC
at 8:30 PM on Sunday, October 25th, 2020
SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. ImagineAR and NFL Alumni Academy recently signed a 5 year partnership agreement. In addition, the company signed a two-year agreement with Valencia C.F. of La Liga to provide interactive Augmented Reality experiences for almost 7 million fans around the world. Learn More.
Seven virtual and augmented reality application areas boosted by global 5G deployment
The market overview includes the education and training industries, public sector, automotive, manufacturing/engineering and robotics, healthcare, retail and hospitality, and gaming and entertainment. It also highlights the challenges and barriers to industry-wide VR/AR adoption and finds that the use cases for VR and AR across sectors will increase significantly with the growth in global 5G deployments.
“Although the adoption of VR/AR technology outside gaming and entertainment is still in its infancy, immediate work needs to be done to establish the use cases and vision for VR/AR and develop solutions to disrupt the predicted spaces,” said Melody Siefken, information & communication technologies research analyst, in a prepared statement. “Countries at the forefront of 5G deployments are the United States, South Korea, and China, with other countries catching up with either mobile or fixed wireless access to 5G.” Siefken added: “There is an optimistic push for 5G deployments to cater to the rising demand for bandwidth and the need for faster networking speed. With the COVID-19 crisis, there has been a slowdown in the supply chain that could delay 5G deployments, which could ultimately impact the use cases of AR/VR.”
According to Frost & Sullivan’s research, market participants should focus on the following industries to capitalize on immense growth prospects:
Education and training: AR/VR could enable remote training and distance learning to create engaging classroom content that accomplishes the same objectives as in-person schooling.
Healthcare: Virtual therapy, vital health monitoring and the opportunity to create platforms for training and exploration are benefits of using AR/VR in healthcare.
Automotive: Aside from driver assistance and customer experience, there are many emerging application areas for VR in the automotive industry. For instance, VR can provide an alternative to new vehicle test-driving, which is safer and cheaper as it eliminates the need for additional vehicles for test driving.
Manufacturing, Engineering and Robotics: The manufacturing industry is being disrupted by the use of VR and AR in design, prototyping, production, prevention of workplace hazards, inventory management, training, and assembly.
Public Sector: AR/VR can enhance emergency management, smart cities and defense programs. Disaster preparedness, real-time information overlay, and personnel training are some of the application areas in the public sector.
Posted by AGORACOM-JC
at 8:29 PM on Sunday, October 25th, 2020
When a $2.7 Billion Dollar Hong Kong listed, Nutrition Focused company holds 11.6% of your stock, agrees to a voluntary 12-month lock up, holds anti-dilution rights to maintain it’s ownership percentage and leads your latest $25,000,000 + financing, it is safe to assume you have a strategic investor who believes in the future of your company.
When that same strategic investor wants to then help your company expand into large international markets, beginning with France and China, it is safe to assume your plant based food capabilities are amongst the most respected in the world.
Else has a $30,000,000 war chest for a US product launch that is commencing here in Q4
US product launch will include store shelves with multiple distributors including one of the largest fresh, natural organic and specialty food distributors in North America
US product launch also includes direct to consumer through Amazon and Else e-commerce site.
Global plans are supported by patents in 22 countries, with another 44 countries pending.
Else developed the world’s first 100% plant based, non-dairy, non-soy baby formula
Pre-launch surveys show extremely high purchase intentions from target market.
Given all of these achievements, it should come as no surprise that Else Nutrition is made up of Executives & Advisors from globally renowned companies and institutions.
If you believe in the future of plant-based, clean label foods or want to discover its possibilities, then watch this great interview with Hamutal Yitzhak, the CEO and Co-Founder of Else Nutrition who discusses the company’s current strengths and plans for global expansion in this very fast moving market.
Posted by AGORACOM-JC
at 8:01 PM on Sunday, October 25th, 2020
HPQ Silicon Resources (HPQ:TSXV) is a Canadian producer of Silicon that is building a line of specialty silicon products needed for electric batteries.
More than just lip service, HPQ has already announced NDA’s with 2 undisclosed companies in the space and has hinted at other NDA’s that are so tight they could not even be announced.
But October 22, 2020 HPQ Silicon went from “a company that is just talking to auto and battery manufacturers to a company that is doing business with a global auto manufacturer” according to CEO Bernard Tourillon, after the Company announced:
Tourillon went to intimate that this order puts HPQ on the global silicon map that he expects to lead to significantly greater interest from the industry.
This was echoed in the press release which stated:
“HPQ NANO is looking forward to the December 2020 start of the Gen1 PUREVAP TM NSiR reactor in order to start delivering material as we work to keep up with the expected strong interest in our Nano Silicon products.”
If that wasn’t enough, PyroGenesis CEO Peter Pascali was even more emphatic when he stated:
“As the technology provider we would be the first to say that nothing is guaranteed. In every new application there will always be challenges along the way, both anticipated and unanticipated. With that in mind, we are happy to note that at this point in time we see nothing that should prevent us from successfully producing the desired powders using PUREVAP TM Nano Silicon Reactor .
5 YEARS ON THE SILICON ROAD LESS TRAVELED
Over the past 5 years, HPQ has teamed up with 2 world renowned technology partners to manufacture high purity silicon cleaner, cheaper and better than anyone in the world – because you can’t dig it out of the ground like other battery metals such as graphite, cobalt and nickel. Now HPQ is on the verge of sending samples of its industry leading silicon to NDA and other potential partners as early as December.
However, despite providing shareholders with a great return during this period, HPQ’s silicon strategy was still met by skepticism amongst investors who found it easier to understand traditional battery metal stories.
TESLA CHANGED EVERYTHING OVERNIGHT
This all changed 7 days ago on September 23rd 2020, when this headline emerged from Tesla’s “Battery Day”
“Tesla To Revolutionize Use Of Silicon In Batteries: Slash Costs, Increases Range”
With the specific references to Silicon + Cheaper Cost + Longer Range, you would have thought HPQ wrote this headline themselves given the fact this is EXACTLY what they have been telling the world for the last 5 years.
Now, thanks to the Company’s latest press release and Tesla’s commitment to silicon, HPQ Silicon no longer has to convince anybody that Silicon is the right track.
If you are serious about battery metals and electric vehicles entering a paradigm shifting parabolic stage in the next 5 years, then you owe it to yourself to watch this interview with CEO Bernard Tourillon.
Ethereum set to become first blockchain to settle $1 trillion in one year
According to crypto market data aggregator Messari, the 30-day rolling daily average for Ethereum transaction volume is currently $7 billion, with Bitcoin processing less than $3 billion.
If the current trend continues, Messari predicts Ethereum will become the first public blockchain to settle $1 trillion in transfers over a calendar year.
The third-quarter decentralized finance boom has resulted in the Ethereum (ETH) network processing more than twice the daily transaction volume of Bitcoin (BTC).
According to crypto market data aggregator Messari, the 30-day rolling daily average for Ethereum transaction volume is currently $7 billion, with Bitcoin processing less than $3 billion.
If the current trend continues, Messari predicts Ethereum will become the first public blockchain to settle $1 trillion in transfers over a calendar year.
Ethereum’s previous strongest calendar year relative to Bitcoin was 2018, when it processed half a billion in volume, which was 59% as much as Bitcoin’s $849 million that year.
Bitcoin is on-track for its second-strongest year behind 2018, projected to process $800 million. Yearly transaction value for Bitcoin and Ethereum: Messari
It’s not a straightforward comparison between the two blockchains, however. With the DeFi bubble largely taking place on top of Ethereum-powered smart contracts, the Ethereum network now processes the volume of an entire sector, while Bitcoin largely represents transfers of value denominated in BTC.
Messari’s Ryan Watkins attributes much of Ethereum’s volume spike to increased ERC-20 stablecoin volumes, with the majority of Tether (USDT) transactions now taking place on Ethereum and yield farming-driven demand pushing supply growth of more than 600% for MakerDAO’s Dai stablecoin.
Watkins also notes booming on-chain liquidity from decentralized exchanges, with Uniswap and Curve generating more than $20 billion in volume combined during September. DEXs now represent more than 13.6% of total exchange volumes.
However, Messari predicts “the next twelve months could come to define the platform wars” in crypto, noting Ethereum’s ongoing high fees as a problem that rival blockchains will seek to solve, alongside “the rise of parallel DeFi ecosystems.”
“Look for all would-be ETH Killers to continue to empty out their treasuries to build a parallel DeFi sector throughout the end of 2020 and beyond.”
In August, Chris Burniske, a partner at PlaceHolder Capital, asserted that Ethereum and Bitcoin are racing each other to reach the first $1 trillion market cap in crypto.
Posted by AGORACOM-JC
at 11:40 AM on Friday, October 23rd, 2020
Else Nutrition Brings Plant-Based Products to the Infant Nutrition Space
Demand for plant-based foods extends far beyond just burgers
One of the companies that has moved to fill a previously unserved segment of the plant-based food market is Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF), an Israel-based food and nutrition company focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults.
The company’s flagship product is a non-soy, non-dairy plant-based infant nutrition formula. Else Nutrition celebrated its US product launch in August with products now available in retail stores and online.
NEW YORK, Oct. 23, 2020 – Over the past few years, plant-based meat and dairy substitutes have gone from a niche product to a major segment in the food industry. Now, these products are increasingly available just about everywhere you look in the food industry. Plant-based options are now available not just in your local grocery store but at your local pub and fast food joint. Plant-based products are now being offered by a wider range of brands from recently IPO’d startups to international giants. These products are also working their way into a wide range of subcategories in the food market, including infant nutrition and diet foods. In the wake of smash plant-based hits like Impossible Foods, companies like Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF) and Forum Merger II (NASDAQ:FMCI) are finding unserved niches in the market, while established food companies like Tyson Foods (NYSE:TSN), ConAgra Brands (NYSE:CAG), and Kellogg (NYSE:K) play catch-up.
Else Nutrition Brings Plant-Based Products to the Infant Nutrition Space
Demand for plant-based foods extends far beyond just burgers. One of the companies that has moved to fill a previously unserved segment of the plant-based food market is Else Nutrition Holdings Inc. (TSXV:BABY) (OTCQX:BABYF), an Israel-based food and nutrition company focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. The company’s flagship product is a non-soy, non-dairy plant-based infant nutrition formula. Else Nutrition celebrated its US product launch in August with products now available in retail stores and online.
On September 24, Else Nutritionannounced that the company had made its products available to US consumers on Amazon.com. The move makes Else’s products available to more consumers than ever via the world’s largest e-commerce platform. Direct-to-consumer online sales are a cornerstone of Else’s go-to-market strategy, particularly as the ongoing global pandemic has driven up demand for products available via delivery. Additionally, Else Nutrition is also pushing to expand its presence in grocery and health food stores. The company announced on August 20 that it had hired a specialized broker to help bring their products to one of the US’s largest retail chains.
Else Nutritionannounced on October 13 that Health and Happiness (H&H) International Holdings Limited, a global health and wellness company and a leading infant nutrition player in China, had increased its investment in the company by C$4.0 million. The private placement, which was previously announced on September 15, now totals C$25.7 million. Else Nutrition plans to use the funds to accelerate and increase its production and supply capabilities, marketing activities, and product development.
Companies Move into the Plant-Based Foods Market
Tyson Foods (NYSE:TSN), the largest meat company in the United States, announced in June that it would be moving into the plant-based meat alternative market. The company announced its new Raised & Rooted brand, which will sell plant-based and mixed meat/plant products. Tyson Foods, with its already massive consumer reach, says it expects plant-based foods to be a billion-dollar business for the company.
ConAgra Brands (NYSE:CAG), the parent company for brands like Orville Redenbacher, Hunts, and Duncan Hines, has been selling meat-free products through its Gardein brand since 2009, but as plant-based meat substitutes have surged in the market, the company is updating its offerings. On September 23, ConAgra announced a line of Gardein soups featuring plant-based meat alternatives.
Kellogg (NYSE:K) got in on the plant-based trend with its Incogmeato line of products. The company is focusing on products aimed at families and young children. To that end, Kellogg announced on September 17 that the company would be partnering with Disney for its latest plant-based offering, Mickey Mouse-branded “Chick’n” Nuggets.
On October 15, holding company Forum Merger II (NASDAQ:FMCI) announced a partnership with plant-based food company Ittella International to form the Tattooed Chef brand. Tattooed Chef will focus on a wide range of meatless foods, some of which will include plant-based meat alternatives.
Plant-based alternatives to meat are the biggest trend in the food industry in years, and the marketplace is filling up fast. Companies like Else Nutrition are positioning themselves within specific, previously unserved segments of the food industry to ensure that they can become the main plant-based players in that space.
DISCLAIMER: Microsmallcap.com (MSC) is the source of the Article and content set forth above. MSC owns and operates Streetsignals.com. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Else Nutrition Holdings.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements.
Media Contact: FN Media Group, LLC [email protected] +1(561)325-8757
Posted by AGORACOM-JC
at 7:35 AM on Friday, October 23rd, 2020
Announced the recent publication of two scientific articles supporting Innocan’s approach of using CBD-Loaded Exosomes (CLX) for the treatment of COVID-19
The first paper entitled, “Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients” published in the Journal of Stem Cell Research & Therapy on October 15, 2020
study demonstrated that exosomes have the ability to enhance alveolar fluid clearance and promote epithelial and endothelial recovery through secretion of protective factors
Demonstrated that the non-psychoactive reagent in cannabis (CBD) can significantly reduce the lung damage induced by cytokine storms
Herzliya, Israel and Calgary, Alberta–(October 23, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce the recent publication of two scientific articles supporting Innocan’s approach of using CBD-Loaded Exosomes (CLX) for the treatment of COVID-19. The first paper entitled, “Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients” published in the Journal of Stem Cell Research & Therapy on October 15, 2020 outlined that mesenchymal stem cells (MSCs) and their exosomes have potential therapeutic functions in the handling of COVID-19. Specifically, the study demonstrated that exosomes have the ability to enhance alveolar fluid clearance and promote epithelial and endothelial recovery through secretion of protective factors.
The second paper entitled, “Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome” published in the Journal of Cellular and Molecular Medicine on October 15, 2020, demonstrated that the non-psychoactive reagent in cannabis (CBD) can significantly reduce the lung damage induced by cytokine storms (which is a physiological reaction in humans and other animals in which the innate immune system causes an uncontrolled and excessive release of pro-inflammatory signaling molecules called cytokines) caused by COVID-19.
Innocan Israel, a wholly owned subsidiary of the Company, together with Tel Aviv University Prof. Daniel Offen and his team, are developing a revolutionary combined therapy using MSC-driven Exosome-based loaded with CBD. The new combination is designed to target COVID-19 and neurodegenerative diseases.
Through their potential synergistic anti-inflammatory effect, CBD-Loaded Exosomes hold the potential of helping the body fight against the COVID-19 virus’s direct damage and its cytokine storm. This product is planned to act as a “guided missile” to the infected tissues, as the Exosomes migrate to Inflamed zones that are carrying CBD.
Prof. Offen added: “The recent publications which support our unique approach is exciting. The potential synergistic effect of CBD and Exosomes is of great potential for COVID-19 and other diseases known for local inflammation that causes destruction. We are doing our best efforts to accelerate the development and to potentially offer a new approach for the COVID-19 treatment”.
About Innocan
Innocan Israel is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD. Innocan Israel and Ramot at Tel Aviv University, are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Coronavirus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.
Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of The Hebrew University of Jerusalem, to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz Head of the Laboratory of Membrane and Liposome Research of The Hebrew University of Jerusalem, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for the relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan Israel each have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.
For further information, please contact:
Innocan Pharma Corporation Iris Bincovich, CEO +972-54-3012842 [email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution regarding forward-looking information
Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable
Posted by AGORACOM-JC
at 3:10 PM on Thursday, October 22nd, 2020
Announced today that the major automobile manufacturer that demonstrated an interest in the Spherical Nano Silicon powders to be produced by the PUREVAPTMNano Silicon Reactor (“NSiR”) ( Sept. 30 2020 release ) has submitted to HPQ NANO a formal Purchase Order for the material
This represents HPQ NANO first ever nanopowders order
Manufacturer is well aware that HPQ NANO will only fulfill this first order in December 2020 and, as such, this order is simply a way for them to guarantee to be first in queue for the material
The automobile manufacture’s name shall remain anonymous for competitive and confidential reasons
MONTREAL, Oct. 22, 2020 — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) ( TSX-V: HPQ ; FWB: UGE ; Other OTC : URAGF ) through its wholly – owned subsidiary, HPQ Nano Silicon Powders inc (“HPQ NANO”), is pleased to announce today that the major automobile manufacturer that demonstrated an interest in the Spherical Nano Silicon powders to be produced by the PUREVAPTMNano Silicon Reactor (“NSiR”) ( Sept. 30 2020 release ) has submitted to HPQ NANO a formal Purchase Order for the material. This represent HPQ NANO first ever nanopowders order. The manufacturer is well aware that HPQ NANO will only fulfill this first order in December 2020 and, as such, this order is simply a way for them to guarantee to be first in queue for the material. The automobile manufacture’s name shall remain anonymous for competitive and confidential reasons.
INTEREST IN OUR SPHERICAL NANO SILICON POWDERS ISJUST STARTING!
HPQ NANO is looking forward to the December 2020 start of the Gen1 PUREVAPTMNSiR reactor in order to start delivering material as we work to keep up with the expected strong interest in our Nano Silicon products.
“This is indeed significant news.To have piqued the interest of a major industrial player so early on, and to the point where theyhave sent us a formal purchase orderfor product,before production,just toinsure their first moverpositionspeaks volumes about where we are and what we are doing,” said Bernard Tourillon, President & CEO of HPQ Silicon and HPQ NANO . “Thisvalidate our strategic decision to enter this space.We are extremely proud as a Company to be at this table at this unique time. However, I must caution investors that although thisordersignalsinterest in our unique products, we are still at the very preliminary stages and there is no guarantee that anything of commercial value will materialize from these efforts. It does however demonstrate the potential for new and exciting advances by HPQNANOin the siliconbatteryspace.”
“This is a remarkable achievement,and one which clearly underscores both the significant underlying interest in such powders and,as such,the potential impact thisproductoffering could haveon theindustry.” said P. Peter Pascali CEO and Chairman of PyroGenesis Canada Inc. “As technology provider we would be the first to say that nothing is guaranteed. In every new application there willalwaysbe challenges along the way, both anticipated and unanticipated.Withthat in mind,we are happy to note thatat this point in time we see nothing that should prevent us fromsuccessfully producing the desired powders usingPUREVAPTMNano Silicon Reactor.”
About Silicon
Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) and the decarbonization of the economy presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO 2 ), in what has historically been a capital and energy intensive process.
About HPQ Silicon
HPQ Silicon Resources Inc. ( TSX-V: HPQ ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high value specialty silicon products needed for the coming RER.
Working with PyroGenesis Canada Inc.(TSX-V: PYR) , a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:
The PUREVAPTM“Quartz Reduction Reactors” (QRR) , an innovative process (patent pending), which will permit the one step transformation of quartz (SiO 2 ) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential ;
HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
Through its 100% owned subsidiary HPQ NANO Silicon Powders Inc, the PUREVAPTMNano Silicon Reactor(NSiR) , a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries ;
During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTMSiNR .
HPQ is also working with industry leader Apollon Solar of France to:
Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries;
Develop the hydrogen generation potential of Silicon nanopowders for usage with the Gennao TM system;
Commercialize, exclusively in Canada, and non-exclusive in the U.S.A., the Gennao TM H2 system and the chemical powders required for the hydrolysis production of Hydrogen (“H2”).
This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Disclaimers:
The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being relatedto the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information contact
Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011 Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239 http://www.hpqsilicon.com Email: [email protected]
Posted by AGORACOM-JC
at 1:42 PM on Thursday, October 22nd, 2020
Announce the appointment of 3-time Olympic Gold Medalist and 5-time World Champion Jennifer Botterill as a Binovi Ambassador and to the Binovi Performance Advisory Board
Will contribute to the development of the Binovi Performance Platform
Jennifer will promote resources within the Binovi Product Platform that are advantageous to sports performance users
October 22, 2020 Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) | ( OTC:BNVIF) is proud to announce the appointment of 3-time Olympic Gold Medalist and 5-time World Champion Jennifer Botterill as a Binovi Ambassador and to the Binovi Performance Advisory Board where she will contribute to the development of the Binovi Performance Platform.
“In bringing on someone of Jennifer’s caliber and expertise to the Binovi Performance Advisory Board, we hope to expand the Binovi offering to even more top-end hockey relationships and their athletes, increasing the already very high skill and performance ceiling seen in professional sports. We’re excited to see what she can bring to the table in our growing industry,” commented Adam Cegielski, Founder and CEO
As a Binovi Ambassador, Jennifer will promote resources within the Binovi Product Platform that are advantageous to sports performance users. She will also assist with the promotion of Binovi to hockey teams and organizations such as current Binovi users the Dallas Stars and Eli Wilson Goaltending . She represents the latest wave of sport influencers supporting technology alongside traditional coaching methods to help improve the performance of athletes of all ages and skill levels. She is amongst an elite group of female athletes actively incorporating performance technology as a skill development resource.
“I am honoured to be a part of the Binovi team. It will be a privilege to collaborate with Binovi to help others achieve the highest level of success that is possible, and I recognize the importance of vision in our lives and in sport performance. I look forward to working closely with Binovi’s cutting edge research & technology to give athletes and individual users the edge to perform at their very best.” commented Jennifer Botterill, Excel In Life, Olympian and World Champion.
“Jennifer has earned herself a place at the top of women’s hockey in Canada and has cemented herself, alongside other greats, as a powerful voice in the sports performance market. Her experience and expertise in international sports, from the World Championship tournaments to Olympic Gold and Silver medals, positions her as a voice of influence when it comes to advanced human performance,” commented Tania Archer, Head of Global Marketing, Commercialization and Strategic Partnerships
Jennifer will be competing in Season 6 of CBC’s Battle of the Blades (premiering Thursday, October 22 at 8 p.m. ET/8:30 p.m. NT), on behalf of The Canadian Cancer Society with two-time World pairs champion and Olympic gold and bronze medalist Eric Radford. Battle of the Blades pairs NHL, Olympic, and professional hockey players with World and Olympic figure skaters in an elimination competition with the hope of winning the grand prize of a $100,000 donation to the charity of their choice. Jennifer will be one of three female hockey players participating in this season’s competition.
About Jennifer Botterill
Jennifer Botterill is one of Canada’s most successful athletes of all-time : she was a member of the Canadian Women’s Hockey Team for fourteen years and competed in 4 Olympic Games; she is a three-time Olympic Gold Medalist (2002, 2006, 2010) , an Olympic silver medalist (1998) and was named to the 2006 Winter Olympic All Tournament Team . She is also a five-time World Champion and was twice (2001, 2004) named the most valuable player of the championship. She also received the Directorate Award as Best Forward (2001) at the IIHF Women’s World Championship. At Vancouver 2010, Jennifer assist ed on the gold medal winning goal.
Jennifer is a graduate of Harvard University, and completed her degree with honours, where she was team captain, won a National Championship, and became the highest scoring collegiate athlete in history. She is the only person to ever win the NCAA female national player of the year award twice.
Jennifer is a keynote speaker, performance coach, consultant, brand ambassador and a television broadcaster. She is an analyst for the NHL’s New York Islanders with MSG Networks. During her career, she has worked with CBC, TSN, and Sportsnet in various roles covering Hockey Canada, the Winter Olympics and the NHL. During the 2019-20 NHL season, Jennifer was an in-studio analyst for NBC’s historic first all-female broadcast team.
She has been a leader for mentorship and has worked as an athlete ambassador for the International Olympic Committee (IOC) at the Youth Olympic Games and the International Ice Hockey Federation (IIHF) to improve the women’s game globally.
Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 9:27 AM on Thursday, October 22nd, 2020
Received 3 nominations from Benzinga’s prestigious Global Fintech Awards; Best API, Innocation During Covid-19, Best Use of Blockchain
Benzina Fintech Top 150 Listmakers is an index of 150 companies & executives within 10 fintech categories that are looking to revolutionize the industry
This year, the 6th Annual Benzinga Global Fintech Awards will take place virtually in November of 2020 and the public will be voting on the winners
TORONTO, ON and GIBRALTAR / October 22, 2020 /KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN” or “KABN North America“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US, is pleased to announce that it has received 3 nominations from Benzinga’s prestigious Global Fintech Awards.
The Benzina Fintech Top 150 Listmakers is an index of 150 companies & executives within 10 fintech categories that are looking to revolutionize the industry. This year, the 6th Annual Benzinga Global Fintech Awards will take place virtually in November of 2020 and the public will be voting on the winners. KABN has been nominated in the following 3 categories:
Working with Benzinga demonstrates how parallel innovative businesses can develop outstanding products. Whether it be research and analysis or engineered success by a team or developers who understand customer needs and KABN is extremely proud to be nominated with many other impressive candidates. The Benzinga Fintech Awards were created to recognize innovation and excellence throughout the capital markets industry.
“This reflects on the hard work of a solid team moving fast and defining a new industry. We are very proud to have been nominated in three categories that recognize not just our bench strength, but our ability to be competitive and customer-forward” said CEO, David Lucatch. “We look forward to contributing and collaborating in the future. We see Benzinga as a strong partner to move our message forward. Their due diligence and professionalism is consistent with our values. We remain committed to enhancing this progress as we expand our market bases.”
The Company would also like to provide an update on its financing activities announced on August 18, 2020 and again on September 16, 2020 with respect to its proposed C$2.97 Million private placement. The Parties have confirmed, although there can be no guarantees, that their intention is to close the funding on or before the end of October, having experienced unforeseen delays, which have since been resolved.
As part of its continuing growth mandate, the Company would like to announce the addition of Mr. David K. Carter, CPA, CA, CFE (USE), CBP as Chief Financial Officer (“CFO”). David Carter is a seasoned management professional in the healthcare and technology sectors, among others, with experience at the intersection between them. Dave first assessed and invested in the Blockchain space in 2016 and views blockchain as uniquely positioned to solve for the significant challenges with identity and records among other use cases. Dave runs his own advisory company established in 2000. His professional qualifications include being a CA and CPA for 25 years, and while with Deloitte he practiced as a forensic investigator. He was a Certified Bitcoin Professional (designated by C4) and spent a year helping design and launch one of Canada’s first cryptoasset funds. Dave has considerable governance experience specifically in the non-profit Directorship arena and earned the ICD’s certification for NFP directors in 2018. Mr. Carter replaces Mr. Bryan Loree, who will now join the Company’s newly formed Industry Advisory Committee.
Additionally, Mr. RJ Reiser is joining the Board of Directors. Mr. Reiser is currently the Company’s Chief Business Development Officer. Mr. Reiser is a proven leader with a history of creating a positive company culture focused on results. He is an energetic professional with an extensive background in growth strategies focused on shareholder value. His career has been focused on transformational technology and has held multiple leadership roles. His leadership and teamwork have contributed to multiple successful exits to Fortune 500 companies. Mr. Reiser replaces Mr. Ben Kessler, Senior Advisor, who will now head up the Company’s Industry Advisory Committee.
The Company issued 645,000 common share stock options to officers and consultants priced at $0.15 with an expiry of 24 months, subject to all securities laws and regulations.
Benzinga is a content ecosystem that makes information easier to consume. Our mission is to connect the world with news, data and education that makes the path to financial prosperity easier for everyone, every day.
From breakouts to unusual volume, analyst ratings, futures and options, Benzinga is the leading ful-service, one-stop shop for investors of all stripes and styles.
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:
Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com
KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.
KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.
Esports: Three Billion Players by 2023 – Image taken from Newzoo website
Yearly transaction value for Bitcoin and Ethereum: 
